• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • OLINK Services
    • Biomarker Data Analyses
  • R&D
  • Products
    • NEUROLINCS
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
    • Your Customized Kit
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media

CLINICAL SAMPLES
Firalis' Biobank
of high quality clinical samples operating under NF S96-900*

4435318284391123-hmqtsqzhpzu.jpg


Firalis has initiated and coordinated several multicentric prospective clinical studies in Europe, with collaboration with the most prestigious University Hospitals and Academic partners, with participation of experienced site coordinators, supervised by independent clinical site monitoring experts and supported by clinical data management experts. From all these past and ongoing clinical studies, Firalis has established and is constantly developing a biobank of its own, consisting of human samples from several Cardiovascular, Neurodegenerative and Rheumatology studies.

Firalis' Biobank is set up according to the highest French standard for biobanking (biological sample management) NF S96-900* and maintained via annual audits performed by AFNOR Certification.

*NF S96-900
NF S96-900 is a French standard that applies to structures that collect, preserve and make available biological resources in accordance with the legislation in force. This norm was developed following an approach consistent with existing documents and in particular, the standard NF EN ISO 9001 and the guidelines of the OECD. It specifies the requirements for a comprehensive quality management system for the collection, transport, storage of biological resources. NF S96-900 not only helps ensure the quality of the samples to users, but also gives patients the assurance that the samples they agreed to donate for research are used in accordance with their will and their privacy.

View Firalis' certificate here

If you are looking for biobank samples for a retrospective validation study, or if you are rather looking forward to set up a collaboration for a product development project, feel free to contact us at sales@firalis.com so we can set up a call to discuss further details.

* * * 

Firalis' Biobank on European Media
> Biobanking Market Analysis 2019- 2025, where Firalis is referred to as one of 20 top European Biobanks
> Alzheimer Europe's publication on Firalis Group's biological samples on dementia

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE